ArticleMycotoxin research2026
In vitro adsorption of Fumonisin B
Article in Mycotoxin research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mycotoxins are toxic secondary metabolites produced by fungi, and frequently encountered in cereals that compose a major part of livestock diets. Fumonisin B1 (FB1) is one of the most prevalent toxins in feed, posing a risk to animal health and productivity. Considering mycotoxin mitigation strategies, adsorbents are an advantageous alternative for reducing mycotoxin uptake by animals. In this context, the main objective of this study was to develop an in vitro protocol for FB1 adsorption and assess the binding efficacy of five formulated products composed of inorganic clay and algae extracts. For this purpose, algae-based formulations were provided by Olmix (Bréhan, France), and multiple parameters were evaluated for in vitro testing, such as pH and mycotoxin concentration. After the selection of adequate conditions, the adsorption capacities of five algae-based products were compared. Results indicate that the adsorption capacity of the algae-based products is mainly linked to the presence of algae, especially green algae; which present a high polysaccharide content in their cell walls as binding sites for mycotoxins. The use of algae for mycotoxin adsorption remains underexplored, but the findings of the present work indicate that algae-based products are effective for FB1 control in animal feed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.